Price: R3,980 (incl. VAT)
Strength: 12mg/0.6ml (3ml pen) – 60mg total
Approx. doses: 30 doses at 2mg (one 28-day course)
What it is
ARA-290 (cibinetide) is an 11-amino-acid peptide derived from erythropoietin (EPO), the body’s own tissue-protection signal. Unlike EPO, it does not stimulate red blood cell production and does not thicken the blood. It activates the Innate Repair Receptor, which switches on the body’s anti-inflammatory and tissue repair pathways after injury, low oxygen or metabolic stress. It is used for nerve pain, especially small fibre and diabetic neuropathy, nerve repair and better microcirculation. Each prefilled pen holds 60mg: one 2mg dose daily for a full 28-day course.
Used for
- Nerve pain, including small fibre and diabetic neuropathy
- Nerve repair and regeneration
- Better microcirculation and blood vessel function
- Neuropathy linked to sarcoidosis (under medical care)
- Clients who want a defined 28-day repair course
ARA-290, also called cibinetide, is an 11-amino-acid peptide derived from erythropoietin (EPO). It activates the body’s Innate Repair Receptor, which switches on anti-inflammatory and tissue repair pathways after injury or stress, without the blood-thickening effect of EPO.
It is studied mainly for small fibre neuropathy. In a randomised trial in sarcoidosis-related small fibre neuropathy it increased small nerve fibre abundance in the cornea and skin. Pain also improved, although that result did not reach statistical significance. The evidence is promising but early stage, so results are individual.
No. ARA-290 is a small fragment designed to keep EPO’s tissue-protective signal while leaving out its effect on red blood cells, so it does not raise your blood count or thicken the blood.
One 2mg dose (10 clicks on the pen) is injected under the skin once a day for 28 days. One 60mg pen covers the full course. Our doctor advises whether a second course is needed.
At mobivIVe, doctor-reviewed ARA-290 is R3,980 per prefilled pen, a full 28-day course, delivered nationwide. Yes, it is dispensed on a valid medical script after a questionnaire reviewed by our registered doctor, with a consultation arranged when your screening calls for one.